Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $128.33, giving the company a market capitalization of 317.5B. It carries a P/E multiple of 35.96 and pays a dividend yield of 2.63%.
During the trading session on 2026-08-05, Merck(MRK) shares reached a daily high of $131.07 and a low of $127.56. At a current price of $128.33, the stock is +0.6% higher than the low and still -2.1% under the high.
Trading activity shows a volume of 9.5M, compared to an average daily volume of 8.57M.
The stock's 52-week range extends from a low of $77.58 to a high of $135.05.
The stock's 52-week range extends from a low of $77.58 to a high of $135.05.
MRK News
Merck (MRK) announced that KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with enfortumab vedotin, an antibody-drug conjugate, is approved by Health Canada...
The race to treat obesity and metabolic disease is reshaping expectations across large pharmaceutical stocks, and Eli Lilly is front and center after its Q2 ear...
...
Analyst ratings
63%
of 30 ratingsMore MRK News
Merck Revenue Tops Estimates Despite Acquisition Charges The company reported an adjusted loss of 13 cents per share, narrower than analysts’ expected loss of...
Goldman Sachs analyst Asad Haider maintained a Buy rating on Merck & Company yesterday and set a price target of $137.00. Claim 55% Off TipRanks Unlock powerful...
(RTTNews) - Merck & Co Inc. (MRK) will host a conference call at 9:00 AM ET on August 4, 2026, to discuss Q2 26 earnings results. o access the live webcast, lo...
(RTTNews) - Merck & Co., Inc. (MRK) reported a GAAP net loss of $1.3 billion in the second quarter of 2026, compared to net income of $4.4 billion in the second...
Merck (MRK) reported second-quarter results that topped Wall Street expectations, driven by continued strength in its blockbuster cancer drug Keytruda, as well...
FY26 consensus $2.76. Raises FY26 revenue view to $66.3B-$67.3B from $65.8B-$67B, consensus $66.89B. Outlook includes charges of $2.43 per share for the acquisi...
Technology The Merck Product That Absolutely Demolished Wall Street's Forecasts Licensing Merck's (MRK) new injectable version of Keytruda walloped sales expect...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.